Your browser doesn't support javascript.
loading
Stabilization and formulation of a recombinant Human Cytomegalovirus vector for use as a candidate HIV-1 vaccine.
Kumru, Ozan S; Saleh-Birdjandi, Soraia; Antunez, Lorena R; Sayeed, Eddy; Robinson, David; van den Worm, Sjoerd; Diemer, Geoffrey S; Perez, Wilma; Caposio, Patrizia; Früh, Klaus; Joshi, Sangeeta B; Volkin, David B.
  • Kumru OS; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS 66047, USA.
  • Saleh-Birdjandi S; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS 66047, USA.
  • Antunez LR; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS 66047, USA.
  • Sayeed E; International AIDS Vaccine Initiative, 125 Broad Street, 9th Floor, New York, NY 10004, USA.
  • Robinson D; Robinson Vaccines and Biologics LLC, New York, NY, USA.
  • van den Worm S; Oregon Health & Science University, Vaccine and Gene Therapy Institute, 505 NW185th Ave, Beaverton, OR 97006, USA.
  • Diemer GS; Oregon Health & Science University, Vaccine and Gene Therapy Institute, 505 NW185th Ave, Beaverton, OR 97006, USA.
  • Perez W; Oregon Health & Science University, Vaccine and Gene Therapy Institute, 505 NW185th Ave, Beaverton, OR 97006, USA.
  • Caposio P; Oregon Health & Science University, Vaccine and Gene Therapy Institute, 505 NW185th Ave, Beaverton, OR 97006, USA.
  • Früh K; Oregon Health & Science University, Vaccine and Gene Therapy Institute, 505 NW185th Ave, Beaverton, OR 97006, USA.
  • Joshi SB; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS 66047, USA.
  • Volkin DB; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS 66047, USA. Electronic address: volkin@ku.edu.
Vaccine ; 37(44): 6696-6706, 2019 10 16.
Article en En | MEDLINE | ID: mdl-31548012

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas Sintéticas / Química Farmacéutica / VIH-1 / Vacunas contra el SIDA / Citomegalovirus / Vectores Genéticos Tipo de estudio: Guideline Límite: Humans Idioma: En Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas Sintéticas / Química Farmacéutica / VIH-1 / Vacunas contra el SIDA / Citomegalovirus / Vectores Genéticos Tipo de estudio: Guideline Límite: Humans Idioma: En Año: 2019 Tipo del documento: Article